CXCL12 and psoriatic arthritis: A study evaluated CXCL12 expression in PsO vulgaris and psoriatic arthritis (PsA) patients concerning disease activity and methotrexate (MTX) therapy, and findings showed significantly higher CXCL12 expression in PsA patients compared to PsO vulgaris patients before treatment but not after.